Healthcare provider profile · identity verified

Gerald S Maxwell, DO

Family Practice · AUSTINTOWN, OH · NPI 1972508711

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	421	117
Amlodipine Besylate	Amlodipine Besylate	380	96
Rosuvastatin Calcium	Rosuvastatin Calcium	302	87
Albuterol Sulfate Hfa	Albuterol Sulfate	257	70
Levothyroxine Sodium	Levothyroxine Sodium	251	62
Losartan Potassium	Losartan Potassium	230	62
Gabapentin	Gabapentin	188	52
Pantoprazole Sodium	Pantoprazole Sodium	187	50
Metoprolol Succinate	Metoprolol Succinate	183	48
Lisinopril	Lisinopril	178	47
Metformin Hcl Er	Metformin Hcl	175	50
Omeprazole	Omeprazole	168	48
Duloxetine Hcl	Duloxetine Hcl	151	38
Fluticasone Propionate	Fluticasone Propionate	141	61
Hydrochlorothiazide	Hydrochlorothiazide	140	36
Eliquis	Apixaban	130	27
Furosemide	Furosemide	121	37
Meloxicam	Meloxicam	119	36
Buspirone Hcl	Buspirone Hcl	118	27
Metformin Hcl	Metformin Hcl	107	30
Metoprolol Tartrate	Metoprolol Tartrate	106	27
Famotidine	Famotidine	95	30
Simvastatin	Simvastatin	91	29
Montelukast Sodium	Montelukast Sodium	89	20
Clopidogrel	Clopidogrel Bisulfate	86	22
Tamsulosin Hcl	Tamsulosin Hcl	79	17
Ozempic	Semaglutide	68	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	13
Potassium Chloride	Potassium Chloride	64	15
Trazodone Hcl	Trazodone Hcl	62	16
Januvia	Sitagliptin Phosphate	60	19
Bupropion Xl	Bupropion Hcl	58	14
Allopurinol	Allopurinol	57	18
Tizanidine Hcl	Tizanidine Hcl	56	18
Benazepril Hcl	Benazepril Hcl	54	15
Carvedilol	Carvedilol	54	18
Pregabalin	Pregabalin	53	11
Sertraline Hcl	Sertraline Hcl	51	15
Alendronate Sodium	Alendronate Sodium	49	16
Escitalopram Oxalate	Escitalopram Oxalate	48	14
Hydralazine Hcl	Hydralazine Hcl	46	suppressed
Ibuprofen	Ibuprofen	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Celecoxib	Celecoxib	41	12
Glimepiride	Glimepiride	40	12
Azelastine Hcl	Azelastine Hcl	39	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	33	12
Valsartan	Valsartan	33	suppressed
Ventolin Hfa	Albuterol Sulfate	33	16
Spironolactone	Spironolactone	32	suppressed
Atenolol	Atenolol	31	11
Warfarin Sodium	Warfarin Sodium	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Torsemide	Torsemide	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Prednisone	Prednisone	27	13
Baclofen	Baclofen	26	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Naproxen	Naproxen	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Lidocaine	Lidocaine	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Colchicine	Colchicine	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Finasteride	Finasteride	11	suppressed
Guanfacine Hcl	Guanfacine Hcl	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nadolol	Nadolol	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nystatin	Nystatin	11	suppressed
Primidone	Primidone	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error